دوره 10، شماره 2 - ( 2-1401 )
جلد 10 شماره 2 صفحات 84-65 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Arianfar F, Tarighi P, Shariatpanahi M, Mousavi Esfahani S M, Mottaghi-Dastjerdi N. Biopharmaceuticals and Nutraceuticals Produced in Yeasts and the Clinical Management Related to COVID-19 Disease. Res Mol Med (RMM) 2022; 10 (2) :65-84
URL: http://rmm.mazums.ac.ir/article-1-456-fa.html
URL: http://rmm.mazums.ac.ir/article-1-456-fa.html
Biopharmaceuticals and Nutraceuticals Produced in Yeasts and the Clinical Management Related to COVID-19 Disease. Research in Molecular Medicine. 1401; 10 (2) :65-84
چکیده: (1661 مشاهده)
Recently, the market demand for biopharmaceuticals and nutraceuticals has increased. Consequently, high-volume production strategies have also drawn a lot of attention. The invention and development of recombinant DNA technology, using various hosts from bacteria to mammalian cells, have led to the industrial-scale manufacture of many valuable pharmaceutical products. Among the hosts, yeasts have a special place due to their numerous benefits. The present study deals with commercial yeast-derived biopharmaceuticals and laboratory-scale yeast-extracted nutraceuticals. It represents the biotechnological potential of yeasts to meet the market's needs in this area. Besides, considering the COVID-19 pandemic, the applications of yeast hosts for the clinical management of this disease have been briefly discussed.
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
